No Data
Investing Pros Haven't Been This Worried About the Stock Market in at Least 28 Years, Our Exclusive Poll Finds
New Cancer Treatments Spark Hope as Traditional Funding Faces Uncertainty
Express News | Tempus Time Network Expands Support of Phase I Clinical Trials to Accelerate Activation and Enrollment
Tempus TIME Network Expands Support of Phase I Clinical Trials To Accelerate Activation and Enrollment
Earnings Preview: Tempus AI to Report Financial Results Post-market on May 06
Tempus AI Publishes XF+ Assay Study Results in Journal of Molecular Diagnostics
Shroomie : no.. it's above the 200 ma now. Just hold
72166072 : MicroStrategy is sending stocks down. it was bad earnings.